101 related articles for article (PubMed ID: 16166326)
21. Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunity.
Tatsumi T; Huang J; Gooding WE; Gambotto A; Robbins PD; Vujanovic NL; Alber SM; Watkins SC; Okada H; Storkus WJ
Cancer Res; 2003 Oct; 63(19):6378-86. PubMed ID: 14559827
[TBL] [Abstract][Full Text] [Related]
22. Peroxynitrite-dependent killing of cancer cells and presentation of released tumor antigens by activated dendritic cells.
Fraszczak J; Trad M; Janikashvili N; Cathelin D; Lakomy D; Granci V; Morizot A; Audia S; Micheau O; Lagrost L; Katsanis E; Solary E; Larmonier N; Bonnotte B
J Immunol; 2010 Feb; 184(4):1876-84. PubMed ID: 20089706
[TBL] [Abstract][Full Text] [Related]
23. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
Kim JW; Wieckowski E; Taylor DD; Reichert TE; Watkins S; Whiteside TL
Clin Cancer Res; 2005 Feb; 11(3):1010-20. PubMed ID: 15709166
[TBL] [Abstract][Full Text] [Related]
24. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis.
Jenne L; Arrighi JF; Jonuleit H; Saurat JH; Hauser C
Cancer Res; 2000 Aug; 60(16):4446-52. PubMed ID: 10969791
[TBL] [Abstract][Full Text] [Related]
25. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
Strome SE; Voss S; Wilcox R; Wakefield TL; Tamada K; Flies D; Chapoval A; Lu J; Kasperbauer JL; Padley D; Vile R; Gastineau D; Wettstein P; Chen L
Cancer Res; 2002 Mar; 62(6):1884-9. PubMed ID: 11912169
[TBL] [Abstract][Full Text] [Related]
26. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
Hatano E; Bennett BL; Manning AM; Qian T; Lemasters JJ; Brenner DA
Gastroenterology; 2001 Apr; 120(5):1251-62. PubMed ID: 11266388
[TBL] [Abstract][Full Text] [Related]
27. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
28. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cells induce the death of human papillomavirus-transformed keratinocytes.
Hubert P; Giannini SL; Vanderplasschen A; Franzen-Detrooz E; Jacobs N; Boniver J; Delvenne P
FASEB J; 2001 Nov; 15(13):2521-3. PubMed ID: 11641258
[TBL] [Abstract][Full Text] [Related]
30. Fas/CD95 down-regulation in lymphoma cells through acquired alkyllysophospholipid resistance: partial role of associated sphingomyelin deficiency.
van Blitterswijk WJ; Klarenbeek JB; van der Luit AH; Alderliesten MC; van Lummel M; Verheij M
Biochem J; 2009 Dec; 425(1):225-34. PubMed ID: 19824885
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of endogenous STAT3 augments tumoricidal activity of interleukin 15 activated dendritic cell against lymphoma and leukemia via TRAIL.
Hira SK; Mondal I; Bhattacharya D; Manna PP
Exp Cell Res; 2014 Oct; 327(2):192-208. PubMed ID: 25139620
[TBL] [Abstract][Full Text] [Related]
32. Effects of D-allose on the endocytic activity of dendritic cells and the subsequent stimulation of T cells.
Tanaka S; Sakamoto H
Cell Immunol; 2011; 271(1):141-6. PubMed ID: 21767830
[TBL] [Abstract][Full Text] [Related]
33. S-nitrosylation of the death receptor fas promotes fas ligand-mediated apoptosis in cancer cells.
Leon-Bollotte L; Subramaniam S; Cauvard O; Plenchette-Colas S; Paul C; Godard C; Martinez-Ruiz A; Legembre P; Jeannin JF; Bettaieb A
Gastroenterology; 2011 Jun; 140(7):2009-18, 2018.e1-4. PubMed ID: 21354149
[TBL] [Abstract][Full Text] [Related]
34. Murine dendritic cell-induced tumor apoptosis is partially mediated by nitric oxide.
Shimamura H; Cumberland R; Hiroishi K; Watkins SC; Lotze MT; Baar J
J Immunother; 2002; 25(3):226-34. PubMed ID: 12000864
[TBL] [Abstract][Full Text] [Related]
35. Tumor antigen-/cytokine-pulsed dendritic cells in therapy against lymphoma.
Hira SK; Verma D; Manna PP
Methods Mol Biol; 2014; 1139():45-56. PubMed ID: 24619670
[TBL] [Abstract][Full Text] [Related]
36. Cutting edge: a novel role for Fas ligand in facilitating antigen acquisition by dendritic cells.
Tada Y; O-Wang J; Takiguchi Y; Tatsumi K; Kuriyama T; Okada S; Tokuhisa T; Sakiyama S; Tagawa M
J Immunol; 2002 Sep; 169(5):2241-5. PubMed ID: 12193688
[TBL] [Abstract][Full Text] [Related]
37. Human allogeneic and murine xenogeneic dendritic cells are cytotoxic to human tumor cells via two distinct pathways.
Schiltz PM; Lee GJ; Zhang JG; Hoa N; Wepsic HT; Dillman RO; Jadus MR
Cancer Biother Radiopharm; 2007 Oct; 22(5):672-83. PubMed ID: 17979570
[TBL] [Abstract][Full Text] [Related]
38. Dendritic cells, T-cells and their possible role in the treatment of leukaemia and lymphoma.
Davison GM
Transfus Apher Sci; 2010 Apr; 42(2):189-92. PubMed ID: 20122870
[TBL] [Abstract][Full Text] [Related]
39. Delayed clearance of apoptotic lymphoma cells allows cross-presentation of intracellular antigens by mature dendritic cells.
Rovere P; Sabbadini MG; Vallinoto C; Fascio U; Zimmermann VS; Bondanza A; Ricciardi-Castagnoli P; Manfredi AA
J Leukoc Biol; 1999 Aug; 66(2):345-9. PubMed ID: 10449179
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide mediated inhibition of antigen presentation from DCs to CD4
Markowitz J; Wang J; Vangundy Z; You J; Yildiz V; Yu L; Foote IP; Branson OE; Stiff AR; Brooks TR; Biesiadecki B; Olencki T; Tridandapani S; Freitas MA; Papenfuss T; Phelps MA; Carson WE
Sci Rep; 2017 Nov; 7(1):15424. PubMed ID: 29133913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
